Cambridge Cognition (LON:COG) Shares Down 9.7% – What’s Next?

Shares of Cambridge Cognition Holdings Plc (LON:COG) were down 9.7% during mid-day trading on Tuesday . The stock traded as low as GBX 27 ($0.35) and last traded at GBX 28 ($0.37). Approximately 156,567 shares were traded during trading, an increase of 172% from the average daily volume of 57,464 shares. The stock had previously closed at GBX 31 ($0.40).

Cambridge Cognition Price Performance

The business’s fifty day moving average is GBX 40.50 and its 200 day moving average is GBX 43.73. The company has a market cap of £11.74 million, a P/E ratio of -751.38 and a beta of 0.72. The company has a current ratio of 0.65, a quick ratio of 0.96 and a debt-to-equity ratio of 92.53.

Cambridge Cognition Company Profile

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.